Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,464 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens.
Furuta J, Inozume T, Harada K, Shimada S. Furuta J, et al. Among authors: shimada s. J Invest Dermatol. 2014 May;134(5):1369-1377. doi: 10.1038/jid.2013.490. Epub 2013 Nov 13. J Invest Dermatol. 2014. PMID: 24226422
Oral administration of the CCR5 inhibitor, maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium.
Matsuzawa T, Kawamura T, Ogawa Y, Takahashi M, Aoki R, Moriishi K, Koyanagi Y, Gatanaga H, Blauvelt A, Shimada S. Matsuzawa T, et al. Among authors: shimada s. J Invest Dermatol. 2013 Dec;133(12):2803-2805. doi: 10.1038/jid.2013.215. Epub 2013 May 6. J Invest Dermatol. 2013. PMID: 23648547 No abstract available.
Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.
Takigawa M, Tokura Y, Shimada S, Furukawa F, Noguchi N, Ito T; Acne Study Group. Takigawa M, et al. Among authors: shimada s. J Dermatol. 2013 Aug;40(8):620-5. doi: 10.1111/1346-8138.12189. Epub 2013 Jun 3. J Dermatol. 2013. PMID: 23724808 Clinical Trial.
Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection.
Ogawa Y, Hasebe R, Ohnuma T, Sano S, Mitsui H, Shimada S, Ishihara H, Sakagami T, Kawamura T. Ogawa Y, et al. Among authors: shimada s. Eur J Dermatol. 2019 Jun 1;29(3):339-341. doi: 10.1684/ejd.2019.3587. Eur J Dermatol. 2019. PMID: 31251217 No abstract available.
Presence of a family history and excessive pressure on the first toe pad during walking in female subjects with pincer nails.
Makino K, Ogawa Y, Kanagawa T, Matsuzawa M, Yamamoto S, Yamada K, Shimada S, Kawamura T, Terada H. Makino K, et al. Among authors: shimada s. J Dermatol. 2019 Jul;46(7):631-633. doi: 10.1111/1346-8138.14931. Epub 2019 May 27. J Dermatol. 2019. PMID: 31131905
Coexistence of anti-topoisomerase I and anti-RNA polymerase III antibody in a patient with overlap syndrome.
Shimizu T, Ogawa Y, Tomita O, Asano Y, Shimada S, Kawamura T. Shimizu T, et al. Among authors: shimada s. Eur J Dermatol. 2019 Feb 1;29(1):93-94. doi: 10.1684/ejd.2018.3475. Eur J Dermatol. 2019. PMID: 30827951 No abstract available.
Zinc transporters in the epidermis.
Ogawa Y, Kinoshita M, Shimada S, Kambe T, Kawamura T. Ogawa Y, et al. Among authors: shimada s. J Dermatol. 2019 Jul;46(7):e243-e245. doi: 10.1111/1346-8138.14797. Epub 2019 Jan 30. J Dermatol. 2019. PMID: 30697795 No abstract available.
Deficiency of the interleukin-36 receptor antagonist dramatically improved by secukinumab.
Kinoshita M, Okamoto T, Sano S, Mitsui H, Takeichi T, Sugiura K, Akiyama M, Shimada S, Kawamura T. Kinoshita M, et al. Among authors: shimada s. J Dermatol. 2018 Oct;45(10):e280-e281. doi: 10.1111/1346-8138.14330. Epub 2018 Apr 17. J Dermatol. 2018. PMID: 29665114 No abstract available.
Efficacy of topical tacrolimus for treating Kyrle's disease.
Kinoshita M, Ogawa Y, Kawamura T, Shimada S. Kinoshita M, et al. Among authors: shimada s. J Dermatol. 2017 May;44(5):e81-e82. doi: 10.1111/1346-8138.13721. Epub 2016 Dec 18. J Dermatol. 2017. PMID: 27988969 No abstract available.
Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins.
Li X, Tsuchisaka A, Qian H, Teye K, Ishii N, Sogame R, Harada K, Nakagomi D, Shimada S, Tateishi C, Hirako Y, Hashimoto T. Li X, et al. Among authors: shimada s. Eur J Dermatol. 2015 Sep-Oct;25(5):418-23. doi: 10.1684/ejd.2015.2555. Eur J Dermatol. 2015. PMID: 26069157 Review.
1,464 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback